Shelley M Herbrich

8PUBLICATIONS
37CO-AUTHORS
Innate immunityMolecular targetsMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 09, 2026
Macrophage-Dendritic Cell-T-Cell Tetrads Orchestrate Antitumor Immunity and Response to Checkpoint Blockade.

Mehdi Chaib, Muhammad Aminu, Shelley Herbrich

|Sep 10, 2025
Loss of PTDSS1 in tumor cells improves immunogenicity and response to anti-PD-1 therapy.

Jielin Liu, Shelley Herbrich, Sreyashi Basu

|Mar 19, 2025
ICOS-expressing CAR-T cells mediate durable eradication of triple-negative breast cancer and metastasis.

Shelley Herbrich, Mehdi Chaib, Padmanee Sharma

|Apr 23, 2022
Targeting the NRF2/HO-1 Antioxidant Pathway in FLT3-ITD-Positive AML Enhances Therapy Efficacy.

Sankaranarayan Kannan, Mary E Irwin, Shelley M Herbrich

|Jul 30, 2021
Overexpression of CD200 is a Stem Cell-Specific Mechanism of Immune Evasion in AML.

Shelley Herbrich, Natalia Baran, Tianyu Cai

Pageof 2